| |
Latest 10 SEC filings (by transaction date) for AVDL within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 4/24 | Feb 20/24 | Kim Richard J | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 147,000 | |
Mar 4/24 | Feb 20/24 | Mchugh Thomas S | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 157,500 | |
Mar 4/24 | Feb 20/24 | Divis Gregory J | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 600,000 | |
Jan 16/24 | Jan 16/24 | Mchugh Thomas S | Direct Ownership | ADSs | P - Open market or private purchase | 2,000 | $14.50 |
Dec 29/23 | Dec 28/23 | McCamish Mark Anthony | Indirect Ownership | ADSs | S - Open market or private sale | -75,000 | $14.53 |
Sep 1/23 | Sep 1/23 | Palczuk Linda | Direct Ownership | Stock Option (Right to Buy) | G - Gift | -33,000 | |
Sep 1/23 | Sep 1/23 | Glass Geoffrey Michael | Direct Ownership | Stock Option (Right to Buy) | G - Gift | -33,000 | |
Aug 14/23 | Aug 14/23 | Mchugh Thomas S | Direct Ownership | ADSs | P - Open market or private purchase | 2,000 | $14.45 |
Aug 15/23 | Aug 11/23 | McCamish Mark Anthony | Indirect Ownership | ADSs | S - Open market or private sale | -28,975 | $14.93 |
Aug 11/23 | Aug 10/23 | Glass Geoffrey Michael | Indirect Ownership | ADSs | P - Open market or private purchase | 14,000 | $13.40 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for AVDL within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 4/24 | Feb 20/24 | Kim Richard J | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 147,000 | |
Mar 4/24 | Feb 20/24 | Mchugh Thomas S | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 157,500 | |
Mar 4/24 | Feb 20/24 | Divis Gregory J | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 600,000 | |
Jan 16/24 | Jan 16/24 | Mchugh Thomas S | Direct Ownership | ADSs | P - Open market or private purchase | 2,000 | $14.50 |
Dec 29/23 | Dec 28/23 | McCamish Mark Anthony | Indirect Ownership | ADSs | S - Open market or private sale | -75,000 | $14.53 |
Sep 1/23 | Sep 1/23 | Palczuk Linda | Direct Ownership | Stock Option (Right to Buy) | G - Gift | -33,000 | |
Sep 1/23 | Sep 1/23 | Glass Geoffrey Michael | Direct Ownership | Stock Option (Right to Buy) | G - Gift | -33,000 | |
Aug 15/23 | Aug 11/23 | McCamish Mark Anthony | Indirect Ownership | ADSs | S - Open market or private sale | -28,975 | $14.93 |
Aug 14/23 | Aug 14/23 | Mchugh Thomas S | Direct Ownership | ADSs | P - Open market or private purchase | 2,000 | $14.45 |
Aug 11/23 | Aug 10/23 | Glass Geoffrey Michael | Indirect Ownership | ADSs | P - Open market or private purchase | 14,000 | $13.40 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Eyepoint Pharmaceuticals (OQ:EYPT) |
AbbVie (N:ABBV) |
Merck & Co (N:MRK) |